Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)
ASH Tsai, HD Chou, XC Ling, T Al-Khaled… - Progress in retinal and …, 2022 - Elsevier
The incidence of retinopathy of prematurity (ROP) continues to rise due to the improved
survival of very low birth weight infants in developed countries. This epidemic is also fueled …
survival of very low birth weight infants in developed countries. This epidemic is also fueled …
Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective
The population of infants at risk for retinopathy of prematurity (ROP) varies by world region;
in countries with well developed neonatal intensive care services, the highest risk infants are …
in countries with well developed neonatal intensive care services, the highest risk infants are …
Reactivation of retinopathy of prematurity after bevacizumab injection
J Hu, MP Blair, MJ Shapiro… - Archives of …, 2012 - jamanetwork.com
Objective To report late reactivation and progression of retinopathy of prematurity (ROP)
after intravitreal bevacizumab monotherapy. Methods Retrospective review of 9 patients (17 …
after intravitreal bevacizumab monotherapy. Methods Retrospective review of 9 patients (17 …
[HTML][HTML] Retinopathy of prematurity: a review of epidemiology and current treatment strategies
EH Hong, YU Shin, H Cho - Clinical and Experimental Pediatrics, 2022 - ncbi.nlm.nih.gov
Retinopathy of prematurity (ROP) is among the most common causes of childhood
blindness. Three phases of ROP epidemics have been observed worldwide since ROP was …
blindness. Three phases of ROP epidemics have been observed worldwide since ROP was …
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings
D Lepore, GE Quinn, F Molle, A Baldascino, L Orazi… - Ophthalmology, 2014 - Elsevier
Purpose To compare the structural outcome at 9 months of eyes treated with intravitreal
injection of bevacizumab with fellow eyes treated with conventional laser photoablation in …
injection of bevacizumab with fellow eyes treated with conventional laser photoablation in …
Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings
D Lepore, GE Quinn, F Molle, L Orazi, A Baldascino… - Ophthalmology, 2018 - Elsevier
Purpose To compare structural outcome at age 4 years of eyes treated with intravitreal
injection of bevacizumab with fellow eyes treated with conventional laser photoablation in …
injection of bevacizumab with fellow eyes treated with conventional laser photoablation in …
An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan
WC Wu, HK Kuo, PT Yeh, CM Yang, CC Lai… - American Journal of …, 2013 - Elsevier
PURPOSE: To investigate the effectiveness and complications associated with the use of
bevacizumab, an anti–vascular endothelial growth factor agent, in the treatment of …
bevacizumab, an anti–vascular endothelial growth factor agent, in the treatment of …
[HTML][HTML] Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options
FM Mutlu, SU Sarici - International Journal of Ophthalmology, 2013 - ncbi.nlm.nih.gov
Retinopathy of prematurity (ROP), a retinal vascular disease of premature infants, continues
to be a major cause of preventable childhood blindness all over the world. The incidence of …
to be a major cause of preventable childhood blindness all over the world. The incidence of …
Are we there yet? Bevacizumab therapy for retinopathy of prematurity
BA Darlow, AL Ells, CE Gilbert, GA Gole… - Archives of Disease in …, 2013 - fn.bmj.com
The publication of the BEAT-ROP study of bevacizumab (Avastin) treatment for Zone I and II
retinopathy of prematurity (ROP) has raised hopes that there might now be a simpler …
retinopathy of prematurity (ROP) has raised hopes that there might now be a simpler …
Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser
M Isaac, K Mireskandari, N Tehrani - Journal of American Association for …, 2015 - Elsevier
Purpose To compare structural outcomes, visual function, refraction, and frequency of follow-
up for infants with type 1 retinopathy of prematurity in zone I or zone II posterior treated with …
up for infants with type 1 retinopathy of prematurity in zone I or zone II posterior treated with …